BIRC3 and neuroblastoma: Under the condition that methylmercury decreased the viability of human neuroblastoma (IMR-32 cells) by 20%, methylmercury increased cleaved caspase-3 levels; on the other hand, mRNA level of BIRC3 was not changed by methylmercury treatment (Fig. 7a–c).